Trial Profile
Clinical Trials Insight: 700024040
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2007
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Fallopian tube cancer; Non-small cell lung cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 22 Jun 2007 New trial record.